New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Application error: a client-side exception has occurred (see the browser console for more information).

New digital health solution for heart failure management puts patients at the center of their care by providing ability for at-home disease monitoring - TOKYO, Sept. 18, 2024 /PRNewswire/ -- Astellas ...

Different methods employ different definitions. Chart-review studies define medication errors as errors in the ordering, transcribing, dispensing, administering, or monitoring of a medication.

Add articles to your saved list and come back to them any time. Over-the-counter medications for heartburn, reflux and morning sickness are at the centre of a class action investigation over ...